Skip to content

Clinical trials

Phase 1 Dyslipidemias trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Phase: Phase 1 Country / region: South Korea Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20131
20143
20154
20163
20175
20183
20194
20202
20216
20227
20233
20243
20253
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed40
Unknown status6
Recruiting3
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chong Kun Dang Pharmaceutical36
AJU Pharm Co., Ltd.3
Korea United Pharm. Inc.3
Yooyoung Pharmaceutical Co., Ltd.2
Yuhan Corporation2
Addpharma Inc.1
Ajou University School of Medicine1
Hyundai Pharm1
IlDong Pharmaceutical Co Ltd1
NVP Healthcare1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias51
Hypertension25
Diabetes Mellitus, Type 22
Hypercholesterolemia1
Peripheral Arterial Disease1

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.